According to the current analysis of Reports and Data, the global Organ Perfusion System market was valued at USD 1.06 billion in 2018 and is expected to reach USD 1.46 billion by the year 2026, at a CAGR of 4.1%. Organ Perfusion Systems are used for storing the organs isolated from the donor’s body under a well-monitored environment to maintain the health of the organ before being transplanted into the receptor’s body. Most commonly perfused organs include the heart, kidney, liver, lungs, and others. Increasing prevalence of heart and respiratory diseases has led to an increase in the rates of organ failure. This is expected to drive the demand for organ transplantations.
Rise in disposable income and changing lifestyle has led to an increase in heart disease cases while excessive alcohol consumption is increasing the rate of kidney failures, thus increasing the demand for kidney transplants. In addition, increasing awareness associated with organ donation has led to an increase in the number of registered organ donors. Increasing pharmaceutical research and growing investments in the new technologies is further expected to expand the market for organ perfusion system.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2232
The Organ Perfusion System market report offers key insights into market scope along with emerging growth opportunities over the forecast period. The report also provides information about the competitive landscape of the global Organ Perfusion System market. The global Organ Perfusion System market is fragmented due to presence of numerous key players on a global and regional scale. Key players are focused on mergers and acquisitions, joint ventures, collaborations, partnerships, and research and development activities to expand their product portfolio and gain a robust footing in the market.
Key companies operating in the Organ Perfusion System Market and profiled in the report are:
Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion AB (Sweden), Repligen corporation and OrganOx.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2232
Further key findings from the report suggest
- Organ Perfusion System market is growing at a CAGR of 5% in Asia Pacific followed by North America and Europe, with 4.2 % and 4.0% CAGR, respectively. High demand for organ transplantation is expected to drive the market for organ perfusion systems.
- As of 2018, Hypothermic is the dominating Organ Perfusion System which holds 64.1% of the global market. North American regional market is the chief revenue generating source for this product segment, followed by Asia-Pacific and European regions
- Presence of government initiatives such as National Organ transplant Programme and other non-profit organization such as Shatayu, Gift Your Organ, Multi Organ Transplantation and Human & Education Research (MOTHER) and many other organizations help in increasing the awareness of organ transplant.
- Introduction of new technology like the living organ transplant that is capable of keeping the organ alive for a longer duration of time after being removed from the body offers new growth opportunities.
- In order to maintain the health of the isolated organ, certain conditions and physiological parameters such as pH, pO2, pH and oxygen levels are required to be monitored. Some organs may require additional equipment and care based on their functions such as the isolated perfused lungs.
- Innovative technology enables easy storage and transplantations of organ from one person to another with reduced risks. The Organ Care System (OCS) Heart, which preserves a donor’s heart in a near-normothermic environment in a beating state until it is replanted in the receptor’s body.
For the purpose of this report, Reports and Data has segmented the Organ Perfusion System market on the basis of type, organ type, technique type, component type, end use, and region:
Type (Revenue, USD Million; 2016–2026)
- Bioreactors perfusion systems
- Microfluidic perfusion systems
- Pressure-driven perfusion systems
Organ Type (Revenue, USD Million; 2016–2026)
- Heart
- Lung
- Liver
- Kidney
- Others
Technique Type (Revenue, USD Million; 2016–2026)
- Hypothermic
- Normothermic
Component Type (Revenue, USD Million; 2016–2026)
- Perfusion Pumps
- Oxygenators
- Heart Lung Machine
- Monitoring Systems
- Cannulas
- Others
End Use (Revenue, USD Million; 2016–2026)
- Hospital
- Clinic
- Ambulatory Surgical Centers
- Others
Regional analysis covers:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report @ https://www.reportsanddata.com/report-detail/organ-perfusion-system-market
Key Questions Answered by the Report:
- What are the key growth driving and restraining factors of the Organ Perfusion System market?
- What are key opportunities and growth prospects of the Organ Perfusion System industry is expected to witness over the forecast period?
- Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
- Which region is expected to dominate the market growth over the forecast period?
- Which segments are expected to register lucrative growth over the forecast period?
- What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2232
Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.
Explore our related report from different Publications:
Acute Myeloid Leukemia Therapeutics Market Research
Cardiac Monitoring Market Growth Rate
Consumer Genomics Market Revenues
Embolization Particles Market Projections
